Skip to main content

The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them

Researchers are hopeful that these pills may also be able to reduce how long someone is infectious or sick—or even prevent people from ending up with long COVID.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.